Corcept Therapeutics Incorporated (CORT) stock analysis

In our weekly check, Corcept Therapeutics Incorporated is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 0, red flags: 4.

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as CORT.

What our checks show for CORT

Red flags

Strengths

Similar companies

KNSA · LQDA · RPRX

Questions

What grade does Corcept Therapeutics Incorporated (CORT) have?

In our weekly check, Corcept Therapeutics Incorporated is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 0, red flags: 4. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of CORT stock?

This week's biggest flags for Corcept Therapeutics Incorporated: Margins falling, Very volatile, Deep past fall. In total 4 of 23 checks show a warning or a red flag.

What does Corcept Therapeutics Incorporated do?

Corcept Therapeutics Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as CORT.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis